Real-world experience with posaconazole prophylaxis in high-risk hematological patients in Singapore: a prospective audit

J Infect. 2013 Mar;66(3):291-4. doi: 10.1016/j.jinf.2012.11.009. Epub 2012 Nov 28.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Administration, Oral
  • Adult
  • Antifungal Agents / administration & dosage*
  • Antifungal Agents / adverse effects
  • Hematologic Diseases / therapy*
  • Hematopoietic Stem Cell Transplantation
  • Humans
  • Immunocompromised Host
  • Medical Audit
  • Middle Aged
  • Mycoses / prevention & control*
  • Prospective Studies
  • Singapore
  • Treatment Outcome
  • Triazoles / administration & dosage*
  • Triazoles / adverse effects

Substances

  • Antifungal Agents
  • Triazoles
  • posaconazole